Skip to content

A prospective, randomized, controlled, non-inferiority trial comparing RF- energy and cryoenergy in pulmonary vein isolation in patients with persistent atrial fibrillation

A prospective, randomized, controlled, non-inferiority trial comparing RF- energy and cryoenergy in pulmonary vein isolation in patients with persistent atrial fibrillation - FreezeAF II

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
DRKS
Registry ID
DRKS00010840
Enrollment
340
Registered
2017-04-26
Start date
2017-11-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I48.1

Interventions

Group 1: Ablation using cryoballon Group 2: Ablation using radiofrequency energy

Sponsors

Medizinische Klinik IVStädtisches Klinikum Karlsruhe
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Documented PersAF: at least 1 episode of PersAF > 7 days and less than 2 years (at least one episode documented) 2. Age 18-80 years 3. Documented inefficacy of at least 1 AAD including beta- blockers 4. Willigness to have rhythm monitoring performed by either internal loop recorder readings or 7 to 14 day external Event recorder reading

Exclusion criteria

Exclusion criteria: 1.LA size > 55 mm 2. LA thrombus 3. Previous LA ablation/surgery 4. Unstable angina 5. Myocardial infarction within three months 6. Cardiac surgery or PTCA within three months 7. Mitral prosthesis 8. EF <40% 9. Heart failure NYHA III-IV 10. Hypertrophic cardiomyopathy 11. Severe or moderate mitral regurgitation 12. Any condition contraindicating chronic anticoagulation 13. Stroke or TIA within six months 14. Thrombocytosis, thrombocytopenia 15. Pregnancy 16. Uncontrolled hyperthyroidism 17. Life expectancy <1year

Design outcomes

Primary

MeasureTime frame
Combined endpoint defined as no episodes of atrial arrhythmias lasting longer that 24 h

Secondary

MeasureTime frame
Time to recurrence of atrial arrhythmia Occurrence of left atrial flutter Early recurrence during blanking perios Atrial arrhythmia of more than 30 seconds Long-term clinical success Total radiation exposure Total procedure duration Bleedings

Countries

Germany

Contacts

Public ContactClaus Schmitt

Medizinische Klinik IVStädtisches Klinikum Karlsruhe

claus.schmitt@klinikum-karlsruhe.de07219742901

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026